Analyst’s Viewpoint regarding Medical Imaging Reagents Market
The reagents that increase the visibility of imaging scans such as MRI, CT scans, and PET scans are critical to effective diagnosis, particularly in detecting diseases in the initial stages. Trends involve moving toward customized imaging agents, thereby employing sophisticated computer technologies to better interpret images.
Key players in this sector focus on innovating to broaden the range of products. This sector significantly impacts the healthcare sector by improving diagnostic accuracy, facilitating earlier detection of health disorders and reducing the cost of treatment in the long term. However, approval delays, high costs, and safety issues with some reagents may inhibit its growth and adoption.
The global market for medical imaging reagents is a vital segment of the healthcare sector, and it plays a crucial role in the development of diagnosis processes by using reagents that help improve the quality and resolution of medical images. Radiopharmaceuticals, contrast agents, and markers are some of the agents applied in imaging modalities like X-Rays, MRIs, CT scans, and ultrasounds. With the growing demand for detecting diseases at an earlier stage, particularly in the field of oncology, cardiology, and neurology, the market is growing immensely.
In the last couple of years, technological advancements have introduced new imaging modalities and reagents that enable non-invasive diagnostic procedures with greater precision. Increasing incidences of chronic ailments and aging population across the globe further boost the demand for efficient diagnostic tools.
Increased investments in healthcare, particularly in emerging economies, also drives the market growth. Collaborations and strategic partnerships between medical device manufacturers, pharma companies, and research organizations that enable the creation of new imaging solutions also drive the market.
Nevertheless, stringent regulatory approvals, pricing, and side-effects of some of the reagents could inhibit growth. Regardless of these challenges, the market is promising due to research and development activities aimed at improving the safety and efficacy of the reagents.
| Attribute | Detail |
|---|---|
| Medical Imaging Reagents Market Drivers |
|
Advancements in medical imaging through better equipment and formulation in reagents have been a key growth driver in the market for reagents in medical imaging. Developments in equipment have led to faster, precise, and non-invasive diagnostic practices that require specialized reagents to support bettering the process of imaging. Enhanced sensitivity and resolutions in advanced equipment employed in MRI scanning, CT scanning, and PET scanning have created demand for efficient reagents to obtain better contrasts and clearer outcomes.
For instance, development has been accelerated by newer MRI scanners with greater magnetic field strengths. This has been met by specialized contrast agents, e.g., gadolinium-based agents, to obtain clearer images. Ongoing push toward personalized medicine and healthcare is also driving specificity in reagents used to detect patterns in diseases in the molecular domain.
This is certain to continue with better medical imaging tools driving greater demand for better reagents to obtain better image quality and diagnostic performance. Besides, market growth in this area is stimulated by emerging diagnostic equipment such as molecular imaging. New equipment is increasingly calling for newer reagents that have not been employed before to stimulate growth and demand in this market. This interplay between growth in equipment in this area and demand in specially created reagents is among the most influential factors in this market growth.
The increased prevalence of diseases including cancer, cardiovascular diseases, neurological diseases, and musculoskeletal diseases has generated a vast demand for reagents in medical imaging. Chronic diseases necessitate early detection and continuous tracking by diagnostic processes in medical imaging including CT, MRI, and PET scanning. Medical imaging reagents in the form of contrast agents support making target tissues and organs visible during scanning to obtain accurate results in diagnoses and better outcomes in patients.
For instance, growing incidence rates of cancer worldwide have stimulated demand to have imaging reagents to support identifying and following growth in tumors, metastasis, and response to therapy. In oncology, contrast agents to better visualize tumors in PET scanning is needed in identifying cancer in an early stage to trigger treatments in time.
In cardiovascular medicine, there is a rising demand for advanced reagents to visualize diseases in blood vessels, cardiac performance, and plaque development in response to growing rates in cardiovascular disease diagnoses worldwide.
Increased incidence rates of these diseases translate to increased demand for diagnostic reagents employed to diagnose, stage, and treat these diseases. This increased incidence is thus among the most influential factors in driving market growth in medical imaging reagents as these reagents constitute an integral part in following these diseases and treating them.
Contrast agents represent the biggest product category in the medical imaging reagent business across the globe due to the role of contrast agents in the enhancement of the quality of images in diagnostic procedures.
Contrast agents render structures within the body visible, and therefore, they are critical components in effective diagnosis. For instance, iodine contrast agents are routinely administered in CT scans to render vessels and organs visible so that tumors or internal bleeding may be more easily interpreted.
For instance, greater use of gadolinium contrast media in MRI scans provides improved imaging of soft tissues, easier diagnosis of neurological disorders such as brain tumors or multiple sclerosis. Additionally, growing incidence of chronic disorders such as cardiovascular disease and cancer, which require complex imaging to chart the correct course of action, further drives demand for contrast media.
With newer imaging technologies, contrast media remain at the center of the process, providing accuracy and contributing to the success of diagnostic procedures.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest medical imaging reagents industry analysis the highest percentage of the medical imaging reagents market globally remained with North America in 2024 due to a number of key drivers. This growth is attributed due to its advanced healthcare infrastructure, high adoption of cutting-edge technologies, and rigorous research and development emphasis.
For instance, the United States boasts several healthcare centers with advanced imaging modalities, which drives the demand for reagents such as contrast media and radiopharmaceuticals. Furthermore, the presence of players such as GE HealthCare, Siemens Healthineers, and Philips also adds to the standing of the region's market.
The aging population in North America, which requires frequent medical imaging for early diagnosis of diseases, also drives demand in the market. The region also offers favorable reimbursement policies enabling hassle-free access to advanced imaging procedures, thus driving demand for quality imaging reagents.
Major players in the medical imaging reagents business worldwide are investing in the areas of innovation, technological advancement, and strategic alliances. They focus on maximizing imaging clarity, incorporating AI, and expanding product portfolios, thus driving ongoing growth and dominance in the dynamic healthcare scenario.
Some of the prominent key players in the medical imaging reagents industry worldwide are Siemens Healthineers AG, Jubilant Pharma Limited, GE HealthCare, Bayer AG, Telix Pharmaceuticals, Eli Lilly and Company, Curium Pharma, IRE ELiT, Bracco Spa, Lantheus Holdings, Inc, CMC Contrast AB, Shimadzu Corporation, PerkinElmer, LI-COR BIOSCIENCES INC., and CARDINAL HEALTH.
Each of the aforementioned players has been detailed in the medical imaging reagents market report on the grounds of factors such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 19.2 Bn |
| Forecast Value in 2035 | US$ 32.4 Bn |
| CAGR | 4.8% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn |
| Medical Imaging Reagents Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation | Product Type
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The medical imaging reagents market was valued at US$ 19.2 Bn in 2024
The medical imaging reagents market is projected to cross US$ 32.4 Bn by the end of 2035
Technological advancements in medical imaging and increasing incidence of chronic diseases
The CAGR is anticipated to be 4.8% from 2025 to 2035
North America is expected to account for the largest share from 2025 to 2035
Siemens Healthineers AG, Jubilant Pharma Limited, GE Healthcare, Bayer AG, Telix Pharmaceuticals, Eli Lilly and Company, Curium Pharma, IRE ELiT, Bracco Spa, Lantheus Holdings, Inc, CMC Contrast AB, Shimadzu Corporation, PerkinElmer, LI-COR BIOSCIENCES INC., CARDINAL HEALTH and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Imaging Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Imaging Reagents Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. PESTEL Analysis
5.3. PORTER's Five Forces Analysis
5.4. Regulatory Landscape across Key Regions / Countries
5.5. Value Chain Analysis
5.6. Technological Advancements
5.7. Unmet Needs of the Market
6. Global Medical Imaging Reagents Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2035
6.3.1. Contrast Agents
6.3.1.1. Iodinated Contrast Agents
6.3.1.2. Gadolinium-Based Contrast Agents
6.3.1.3. Barium-Based Contrast Agents
6.3.1.4. Others
6.3.2. Nuclear Imaging Reagents
6.3.2.1. Technetium-99m-based Reagents
6.3.2.2. Fluorine-18-based Reagents
6.3.2.3. Gallium-68-based
6.3.2.4. Others
6.3.3. Fluorescent Dyes and Probes
6.3.3.1. Indocyanine Green (ICG)
6.3.3.2. Fluorescein
6.3.3.3. NIR Dyes
6.3.3.4. Bioluminescent Probes
6.3.3.5. Others
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Imaging Reagents Market Analysis and Forecast, by Imaging Modality
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Imaging Modality, 2020-2035
7.3.1. X-ray & Computed Tomography (CT)
7.3.2. Magnetic Resonance Imaging (MRI)
7.3.3. Ultrasound
7.3.4. Nuclear Imaging Modalities
7.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
7.3.6. Others
7.4. Market Attractiveness Analysis, by Imaging Modality
8. Global Medical Imaging Reagents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2035
8.3.1. Cardiology
8.3.2. Oncology
8.3.3. Neurology
8.3.4. Gastroenterology
8.3.5. Orthopedics
8.3.6. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Medical Imaging Reagents Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Hospitals
9.3.2. Imaging Centers
9.3.3. Specialty Centers
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Medical Imaging Reagents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Medical Imaging Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2035
11.2.1. Contrast Agents
11.2.1.1. Iodinated Contrast Agents
11.2.1.2. Gadolinium-Based Contrast Agents
11.2.1.3. Barium-Based Contrast Agents
11.2.1.4. Others
11.2.2. Nuclear Imaging Reagents
11.2.2.1. Technetium-99m-based Reagents
11.2.2.2. Fluorine-18-based Reagents
11.2.2.3. Gallium-68-based
11.2.2.4. Others
11.2.3. Fluorescent Dyes and Probes
11.2.3.1. Indocyanine Green (ICG)
11.2.3.2. Fluorescein
11.2.3.3. NIR Dyes
11.2.3.4. Bioluminescent Probes
11.2.3.5. Others
11.2.4. Others
11.3. Market Value Forecast, by Imaging Modality, 2020-2035
11.3.1. X-ray & Computed Tomography (CT)
11.3.2. Magnetic Resonance Imaging (MRI)
11.3.3. Ultrasound
11.3.4. Nuclear Imaging Modalities
11.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
11.3.6. Others
11.4. Market Value Forecast, by Application, 2020-2035
11.4.1. Cardiology
11.4.2. Oncology
11.4.3. Neurology
11.4.4. Gastroenterology
11.4.5. Orthopedics
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Hospitals
11.5.2. Imaging Centers
11.5.3. Specialty Centers
11.5.4. Others
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Imaging Modality
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Medical Imaging Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2035
12.2.1. Contrast Agents
12.2.1.1. Iodinated Contrast Agents
12.2.1.2. Gadolinium-Based Contrast Agents
12.2.1.3. Barium-Based Contrast Agents
12.2.1.4. Others
12.2.2. Nuclear Imaging Reagents
12.2.2.1. Technetium-99m-based Reagents
12.2.2.2. Fluorine-18-based Reagents
12.2.2.3. Gallium-68-based
12.2.2.4. Others
12.2.3. Fluorescent Dyes and Probes
12.2.3.1. Indocyanine Green (ICG)
12.2.3.2. Fluorescein
12.2.3.3. NIR Dyes
12.2.3.4. Bioluminescent Probes
12.2.3.5. Others
12.2.4. Others
12.3. Market Value Forecast, by Imaging Modality, 2020-2035
12.3.1. X-ray & Computed Tomography (CT)
12.3.2. Magnetic Resonance Imaging (MRI)
12.3.3. Ultrasound
12.3.4. Nuclear Imaging Modalities
12.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
12.3.6. Others
12.4. Market Value Forecast, by Application, 2020-2035
12.4.1. Cardiology
12.4.2. Oncology
12.4.3. Neurology
12.4.4. Gastroenterology
12.4.5. Orthopedics
12.4.6. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Hospitals
12.5.2. Imaging Centers
12.5.3. Specialty Centers
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Imaging Modality
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Medical Imaging Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2035
13.2.1. Contrast Agents
13.2.1.1. Iodinated Contrast Agents
13.2.1.2. Gadolinium-Based Contrast Agents
13.2.1.3. Barium-Based Contrast Agents
13.2.1.4. Others
13.2.2. Nuclear Imaging Reagents
13.2.2.1. Technetium-99m-based Reagents
13.2.2.2. Fluorine-18-based Reagents
13.2.2.3. Gallium-68-based
13.2.2.4. Others
13.2.3. Fluorescent Dyes and Probes
13.2.3.1. Indocyanine Green (ICG)
13.2.3.2. Fluorescein
13.2.3.3. NIR Dyes
13.2.3.4. Bioluminescent Probes
13.2.3.5. Others
13.2.4. Others
13.3. Market Value Forecast, by Imaging Modality, 2020-2035
13.3.1. X-ray & Computed Tomography (CT)
13.3.2. Magnetic Resonance Imaging (MRI)
13.3.3. Ultrasound
13.3.4. Nuclear Imaging Modalities
13.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
13.3.6. Others
13.4. Market Value Forecast, by Application, 2020-2035
13.4.1. Cardiology
13.4.2. Oncology
13.4.3. Neurology
13.4.4. Gastroenterology
13.4.5. Orthopedics
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2020-2035
13.5.1. Hospitals
13.5.2. Imaging Centers
13.5.3. Specialty Centers
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Imaging Modality
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Medical Imaging Reagents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2035
14.2.1. Contrast Agents
14.2.1.1. Iodinated Contrast Agents
14.2.1.2. Gadolinium-Based Contrast Agents
14.2.1.3. Barium-Based Contrast Agents
14.2.1.4. Others
14.2.2. Nuclear Imaging Reagents
14.2.2.1. Technetium-99m-based Reagents
14.2.2.2. Fluorine-18-based Reagents
14.2.2.3. Gallium-68-based
14.2.2.4. Others
14.2.3. Fluorescent Dyes and Probes
14.2.3.1. Indocyanine Green (ICG)
14.2.3.2. Fluorescein
14.2.3.3. NIR Dyes
14.2.3.4. Bioluminescent Probes
14.2.3.5. Others
14.2.4. Others
14.3. Market Value Forecast, by Imaging Modality, 2020-2035
14.3.1. X-ray & Computed Tomography (CT)
14.3.2. Magnetic Resonance Imaging (MRI)
14.3.3. Ultrasound
14.3.4. Nuclear Imaging Modalities
14.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
14.3.6. Others
14.4. Market Value Forecast, by Application, 2020-2035
14.4.1. Cardiology
14.4.2. Oncology
14.4.3. Neurology
14.4.4. Gastroenterology
14.4.5. Orthopedics
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2020-2035
14.5.1. Hospitals
14.5.2. Imaging Centers
14.5.3. Specialty Centers
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Imaging Modality
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Medical Imaging Reagents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2035
15.2.1. Contrast Agents
15.2.1.1. Iodinated Contrast Agents
15.2.1.2. Gadolinium-Based Contrast Agents
15.2.1.3. Barium-Based Contrast Agents
15.2.1.4. Others
15.2.2. Nuclear Imaging Reagents
15.2.2.1. Technetium-99m-based Reagents
15.2.2.2. Fluorine-18-based Reagents
15.2.2.3. Gallium-68-based
15.2.2.4. Others
15.2.3. Fluorescent Dyes and Probes
15.2.3.1. Indocyanine Green (ICG)
15.2.3.2. Fluorescein
15.2.3.3. NIR Dyes
15.2.3.4. Bioluminescent Probes
15.2.3.5. Others
15.2.4. Others
15.3. Market Value Forecast, by Imaging Modality, 2020-2035
15.3.1. X-ray & Computed Tomography (CT)
15.3.2. Magnetic Resonance Imaging (MRI)
15.3.3. Ultrasound
15.3.4. Nuclear Imaging Modalities
15.3.5. Hybrid Modalities (PET/CT, PET/MRI, etc.)
15.3.6. Others
15.4. Market Value Forecast, by Application, 2020-2035
15.4.1. Cardiology
15.4.2. Oncology
15.4.3. Neurology
15.4.4. Gastroenterology
15.4.5. Orthopedics
15.4.6. Others
15.5. Market Value Forecast, by End-user, 2020-2035
15.5.1. Hospitals
15.5.2. Imaging Centers
15.5.3. Specialty Centers
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Imaging Modality
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis, by Company (2024)
16.3. Company Profiles
16.3.1. Siemens Healthineers AG
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. Jubilant Pharma Limited
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. GE Healthcare
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Bayer AG
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Telix Pharmaceuticals
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Eli Lilly and Company
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Curium Pharma
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. IRE ELiT
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Bracco Spa
16.3.9.1. Company Overview
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Business Strategies
16.3.9.5. Recent Developments
16.3.10. Lantheus Holdings, Inc
16.3.10.1. Company Overview
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Business Strategies
16.3.10.5. Recent Developments
16.3.11. CMC Contrast AB
16.3.11.1. Company Overview
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. Business Strategies
16.3.11.5. Recent Developments
16.3.12. Shimadzu Corporation
16.3.12.1. Company Overview
16.3.12.2. Financial Overview
16.3.12.3. Product Portfolio
16.3.12.4. Business Strategies
16.3.12.5. Recent Developments
16.3.13. PerkinElmer
16.3.13.1. Company Overview
16.3.13.2. Financial Overview
16.3.13.3. Product Portfolio
16.3.13.4. Business Strategies
16.3.13.5. Recent Developments
16.3.14. LI-COR BIOSCIENCES INC.
16.3.14.1. Company Overview
16.3.14.2. Financial Overview
16.3.14.3. Product Portfolio
16.3.14.4. Business Strategies
16.3.14.5. Recent Developments
16.3.15. CARDINAL HEALTH
16.3.15.1. Company Overview
16.3.15.2. Financial Overview
16.3.15.3. Product Portfolio
16.3.15.4. Business Strategies
16.3.15.5. Recent Developments
List of Tables
Table 01: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 02: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 03: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 04: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 05: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 06: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 07: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 08: Global Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 09: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 10: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 11: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 12: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 13: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 14: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 15: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 16: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 17: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 18: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 19: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 20: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 21: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 22: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 23: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 24: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 25: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 26: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 27: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 28: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 29: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 30: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 31: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 32: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 33: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 34: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 35: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 36: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 37: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 38: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 39: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 40: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 41: Middle East & Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 42: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
Table 43: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Iodinated Contrast Agents, 2020-2035
Table 44: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Nuclear Imaging Reagents, 2020-2035
Table 45: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Fluorescent Dyes and Probes, 2020-2035
Table 46: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Imaging Modality, 2020-2035
Table 47: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 48: Middle East and Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
List of Figures
Figure 01: Global Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 02: Global Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 03: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Contrast Agents, 2020-2035
Figure 04: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Nuclear Imaging Reagents, 2020-2035
Figure 05: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Fluorescent Dyes and Probes, 2020-2035
Figure 06: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Others, 2020-2035
Figure 07: Global Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 08: Global Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 09: Global Medical Imaging Reagents Market Revenue (US$ Bn), by X-ray & Computed Tomography (CT), 2020-2035
Figure 10: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Magnetic Resonance Imaging (MRI), 2020-2035
Figure 11: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Ultrasound, 2020-2035
Figure 12: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Nuclear Imaging Modalities, 2020-2035
Figure 13: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Hybrid Modalities (PET/CT, PET/MRI, etc.), 2020-2035
Figure 14: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Others, 2020-2035
Figure 15: Global Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 16: Global Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 17: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Cardiology, 2020-2035
Figure 18: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Oncology, 2020-2035
Figure 19: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Neurology, 2020-2035
Figure 20: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Gastroenterology, 2020-2035
Figure 21: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Orthopedics, 2020-2035
Figure 22: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Others, 2020-2035
Figure 23: Global Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 24: Global Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Figure 25: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Hospitals, 2020-2035
Figure 26: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Imaging Centers, 2020-2035
Figure 27: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Specialty Centers, 2020-2035
Figure 28: Global Medical Imaging Reagents Market Revenue (US$ Bn), by Others, 2020-2035
Figure 29: Global Medical Imaging Reagents Market Value Share Analysis, By Region, 2024 and 2035
Figure 30: Global Medical Imaging Reagents Market Attractiveness Analysis, By Region, 2025-2035
Figure 31: North America Medical Imaging Reagents Market Value (US$ Bn) Forecast, 2020-2035
Figure 32: North America Medical Imaging Reagents Market Value Share Analysis, by Country, 2024 and 2035
Figure 33: North America Medical Imaging Reagents Market Attractiveness Analysis, by Country, 2025-2035
Figure 34: North America Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 35: North America Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 36: North America Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 37: North America Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 38: North America Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 39: North America Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 40: North America Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 41: North America Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Figure 42: Europe Medical Imaging Reagents Market Value (US$ Bn) Forecast, 2020-2035
Figure 43: Europe Medical Imaging Reagents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 44: Europe Medical Imaging Reagents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 45: Europe Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 46: Europe Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 47: Europe Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 48: Europe Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 49: Europe Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 50: Europe Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 51: Europe Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 52: Europe Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Figure 53: Asia Pacific Medical Imaging Reagents Market Value (US$ Bn) Forecast, 2020-2035
Figure 54: Asia Pacific Medical Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 55: Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 56: Asia Pacific Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 57: Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 58: Asia Pacific Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 59: Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 60: Asia Pacific Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 61: Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 62: Asia Pacific Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 63: Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Figure 64: Latin America Medical Imaging Reagents Market Value (US$ Bn) Forecast, 2020-2035
Figure 65: Latin America Medical Imaging Reagents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 66: Latin America Medical Imaging Reagents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 67: Latin America Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 68: Latin America Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 69: Latin America Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 70: Latin America Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 71: Latin America Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 72: Latin America Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 73: Latin America Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 74: Latin America Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Figure 75: Middle East & Africa Medical Imaging Reagents Market Value (US$ Bn) Forecast, 2020-2035
Figure 76: Middle East & Africa Medical Imaging Reagents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 77: Middle East & Africa Medical Imaging Reagents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 78: Middle East and Africa Medical Imaging Reagents Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 79: Middle East and Africa Medical Imaging Reagents Market Attractiveness Analysis, By Product Type, 2025-2035
Figure 80: Middle East and Africa Medical Imaging Reagents Market Value Share Analysis, By Imaging Modality, 2024 and 2035
Figure 81: Middle East and Africa Medical Imaging Reagents Market Attractiveness Analysis, By Imaging Modality, 2025-2035
Figure 82: Middle East and Africa Medical Imaging Reagents Market Value Share Analysis, By Application, 2024 and 2035
Figure 83: Middle East and Africa Medical Imaging Reagents Market Attractiveness Analysis, By Application, 2025-2035
Figure 84: Middle East and Africa Medical Imaging Reagents Market Value Share Analysis, By End-user, 2024 and 2035
Figure 85: Middle East and Africa Medical Imaging Reagents Market Attractiveness Analysis, By End-user, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Medical Imaging Reagents Market
